Changes in type VI collagen degradation reflect clinical response to treatment in rheumatoid arthritis patients treated with tocilizumab
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Changes in type VI collagen degradation reflect clinical response to treatment in rheumatoid arthritis patients treated with tocilizumab ; volume:26 ; number:1 ; day:2 ; month:1 ; year:2024 ; pages:1-10 ; date:12.2024
Arthritis Research & Therapy ; 26, Heft 1 (2.1.2024), 1-10, 12.2024
- Urheber
-
Thudium, Christian S.
Frederiksen, Peder
Karsdal, Morten A.
Bay-Jensen, Anne-Christine
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-023-03242-0
- URN
-
urn:nbn:de:101:1-2024031409292159851559
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Thudium, Christian S.
- Frederiksen, Peder
- Karsdal, Morten A.
- Bay-Jensen, Anne-Christine
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tocilizumab: A Review in Rheumatoid Arthritis
Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
Tocilizumab degradation via photo-catalytic ozonation process from aqueous
Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies
Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies
Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry
Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapy
Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
Concomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis
Tocilizumab: A Review in Rheumatoid Arthritis
Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
Tocilizumab degradation via photo-catalytic ozonation process from aqueous
Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies
Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies
Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry
Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapy
Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
Concomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis
Tocilizumab: A Review in Rheumatoid Arthritis
Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
Tocilizumab degradation via photo-catalytic ozonation process from aqueous
Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies
Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies
Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry
Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapy
Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series